SORT1 and polycystic ovary syndrome: Recent reviews, such as Verma et al., suggest that AI-based diagnostic models may help refine biomarker identification in PCOS, emphasizing the need to integrate sortilin into future computational models for enhanced diagnostic accuracy [15].